MYND Life Sciences (TSE:MYND) has released an update.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
MYND Life Sciences plans to issue 4 million shares to eliminate $3.5 million in debt, including restructuring an outstanding debenture, to enhance shareholder value and focus on developing their biomarker test for depression. This strategic financial move aims to strengthen MYND’s position and accelerate the development of a potentially groundbreaking diagnostic tool for major depressive disorder.
For further insights into TSE:MYND stock, check out TipRanks’ Stock Analysis page.